WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001032708) COMPOUNDS, ANTIBODIES AND METHODS FOR TREATING, PREVENTING OR DIAGNOSING TUMOUR METASTASIS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/032708 International Application No.: PCT/SE1999/002009
Publication Date: 10.05.2001 International Filing Date: 05.11.1999
Chapter 2 Demand Filed: 05.06.2001
IPC:
A61K 38/00 (2006.01) ,C07K 14/475 (2006.01) ,C07K 16/22 (2006.01)
Applicants: JÖNSSON, Marzieh[SE/SE]; SE (UsOnly)
ANDERSSON, Tommy[SE/SE]; SE (UsOnly)
FORSKARPATENT I SYD AB[SE/SE]; Ideon S-223 70 Lund, SE (AllExceptUS)
Inventors: JÖNSSON, Marzieh; SE
ANDERSSON, Tommy; SE
Agent: IVERSEN HASSELROT, Eva ; Allied Attorneys Chemical AB P.O. Box 24107 S-104 51 Stockholm, SE
FOGELBERG, Lennart ; Allied Attorneys Chemical AB P.O. Box 24107 S-104 51 Stockholm, SE
Priority Data:
Title (EN) COMPOUNDS, ANTIBODIES AND METHODS FOR TREATING, PREVENTING OR DIAGNOSING TUMOUR METASTASIS
(FR) COMPOSES, ANTICORPS ET METHODES DESTINES AU TRAITEMENT, A LA PREVENTION OU AU DIAGNOSTIC DE LA METASTASE DES TUMEURS
Abstract:
(EN) The present invention relates to a novel synthesised peptide-analogue, including the functional domain of the Wnt-5a protein, a composition comprising the synthesised peptide-analogue, an antibody used as a diagnostic agent. The present invention also relates to uses of the compound for the manufacture of a medicament or a diagnostic agent in the treatment of metastasis or the diagnosing of metastasis.
(FR) La présente invention concerne un nouvel analogue peptidique de synthèse comprenant le domaine fonctionnel de la protéine Wnt-5a, une composition renfermant ledit analogue peptidique de synthèse, et un anticorps utilisé comme agent de diagnostic. La présente invention concerne également les utilisations de ce composé pour la fabrication d'un médicament ou d'un agent de diagnostic destiné au traitement ou au diagnostic de la métastase.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)